| Torrent Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500420 |
NSE Symbol : TORNTPHARM |
P/E(TTM) : 92.69 |
|
ISIN Demat : INE685A01028 |
Div & Yield% : 0.68 |
EPS(TTM) : 53.92 |
|
Book Value(₹) : 222.76 |
Market Cap(₹Cr) : 190,107.85 |
Face Value(₹) : 5.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 10,713.14 | 9,683.43 | 8,532.90 | 7,695.20 | 6,742.32 |
| Other Income | 17.92 | 31.50 | 91.36 | 81.88 | 204.17 |
| Stock Adjustments | 22.28 | 9.04 | 68.61 | -128.44 | 18.34 |
| Total Income | 10,753.34 | 9,723.97 | 8,692.87 | 7,648.64 | 6,964.83 |
| EXPENDITURE : | |||||
| Raw Materials | 2,334.64 | 2,249.84 | 2,200.39 | 2,010.98 | 1,925.84 |
| Power and Fuel Cost | 138.74 | 134.25 | 143.43 | 153.21 | 140.00 |
| Other Manufacturing Expenses | 227.68 | 189.02 | 173.82 | 143.39 | 141.56 |
| Selling and Administration Expenses | 1,558.61 | 1,397.82 | 1,254.38 | 1,138.57 | 954.66 |
| Miscellaneous Expenses | 613.16 | 533.53 | 489.52 | 404.23 | 399.91 |
| Employee Benefit Expenses | 1,879.40 | 1,636.45 | 1,450.67 | 1,251.22 | 1,097.93 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 4,001.11 | 3,583.06 | 2,980.66 | 2,547.04 | 2,304.93 |
| Interest | 340.96 | 213.40 | 303.04 | 297.68 | 236.29 |
| Gross Profit | 3,660.15 | 3,369.66 | 2,677.62 | 2,249.36 | 2,068.64 |
| Depreciation | 763.54 | 759.48 | 761.05 | 672.34 | 602.43 |
| Profit Before Tax | 2,896.61 | 2,610.18 | 1,916.57 | 1,577.02 | 1,466.21 |
| Current Tax | 720.20 | 540.56 | 321.67 | 274.20 | 253.27 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -15.18 | 181.56 | 237.82 | 251.43 | 221.49 |
| Reported Net Profit | 2,191.59 | 1,888.06 | 1,357.08 | 1,051.39 | 991.45 |
| Extraordinary Items | -20.93 | -4.20 | 14.88 | 27.97 | 6.86 |
| Adjusted Net Profit | 2,212.52 | 1,892.26 | 1,342.20 | 1,023.42 | 984.59 |
| Adjustment below Net Profit | -4.60 | -27.14 | 0.44 | -7.07 | -1.55 |
| Profit/Loss Balance carried down | 4,514.33 | 3,736.39 | 3,394.21 | 3,212.92 | 2,899.91 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 1,184.53 | 1,082.98 | 1,015.34 | 863.03 | 676.89 |
| P & L Balance carried down | 5,516.79 | 4,514.33 | 3,736.39 | 3,394.21 | 3,212.92 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 760.00 | 640.00 | 560.00 | 440.00 | 960.00 |
| Dividend Per Share(Rs) | 38.00 | 32.00 | 28.00 | 22.00 | 48.00 |
| Earnings Per Share-Unit Curr | 64.75 | 55.78 | 40.10 | 31.06 | 58.58 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 249.72 | 224.32 | 201.76 | 190.75 | 374.94 |
| Book Value(Adj)-Unit Curr | 249.72 | 224.32 | 201.76 | 190.75 | 187.47 |
